Huiqing Jiang | Nucleic Acid | Outstanding Contribution Award

Prof. Huiqing Jiang | Nucleic Acid | Outstanding Contribution Award

Prof. Huiqing Jiang | Hebei Medical University | China

Prof. Huiqing Jiang is a distinguished Professor, Chief Physician, and Doctoral Supervisor at The Second Hospital of Hebei Medical University, where he also serves as Director of the Hebei Institute of Digestive Diseases and the Hebei Key Laboratory of Digestive Diseases. A recipient of the prestigious Special Government Allowance from the State Council of China, he has made outstanding contributions to the diagnosis and treatment of digestive system diseases. His clinical expertise encompasses endoscopic diagnosis and therapeutic interventions for gastrointestinal disorders, including endoscopic resection of early cancers and polyps, stricture dilation, stent placement, treatment of esophageal varices in cirrhosis, and biliary stone extraction with pancreatic stent insertion. As a pioneer in Hebei Province, he has introduced and advanced multiple endoscopic techniques that have transformed clinical practice and improved patient outcomes. His research primarily focuses on chronic liver diseases, particularly liver fibrosis, and gastrointestinal tumors, where he has established himself as a leading authority in digestive disease research. Prof. Jiang has served as the principal investigator for two National Natural Science Foundation of China projects and has successfully completed six provincial-level projects, earning significant recognition for his innovative contributions. His work has been honored with several prestigious awards, including the First-Class Prize of the Provincial Scientific and Technological Progress Award, three Third-Class Prizes, and the Young Teachers Award from the Huo Yingdong Education Foundation. He has published an impressive 160 peer-reviewed papers, including 11 SCI-indexed articles, with his highest impact publication appearing in the Journal of Hepatology (Impact Factor 9.334). His academic influence is reflected in his citation record of 1,866 citations across 1,714 documents and an h-index of 24, showcasing his sustained scholarly impact in the field. Additionally, he has edited or co-authored 16 authoritative medical textbooks such as Internal Medicine, Diagnostics, and Clinical Hepatology, contributing extensively to medical education and training. Prof. Jiang also holds significant editorial responsibilities, serving as Associate Editor-in-Chief of Gastroenterology and Hepatology and as a board member of several core medical journals. His leadership extends to professional associations as Standing Committee Member of the Chinese Society of Digestive Endoscopy and the Endoscopist Branch of the Chinese Medical Doctor Association, and as Chairman of both the Hebei Branch of the Digestive Endoscopist Association and the Hebei Society of Gastroenterology.

Profile:  Scopus

Featured Publications

piR-19521 facilitates cancer stem cell-like properties by enhancing ALX4 transcription via an enhancer RNA-like mechanism in colorectal cancer. International Journal of Biological Macromolecules.

Correction to: The role of the apoptosis-related protein BCL-B in the regulation of mitophagy in hepatic stellate cells during the regression of liver fibrosis. Experimental & Molecular Medicine, 51(1), 1–13.

Identification and validation of a novel predictive signature based on hepatocyte-specific genes in hepatocellular carcinoma by integrated analysis of single-cell and bulk RNA sequencing. BMC Medical Genomics.

Development and validation of risk prediction model for bacterial infections in acute liver failure patients. European Journal of Gastroenterology & Hepatology.

Effect of oxaliplatin on the activation of hepatic stellate cells and its mechanism. Journal of Clinical Hepatology.

Development and validation of a new prognostic model for patients with acute-on-chronic liver failure in intensive care unit. World Journal of Gastroenterology.

Identification of oxidative stress-related biomarkers associated with the development of acute-on-chronic liver failure using bioinformatics. Scientific Reports.

Evaluation of ITGB1 expression as a predictor of the therapeutic effects of immune checkpoint inhibitors in gastric cancer. BMC Gastroenterology.

Saloni Sinha | Biochemistry | Best Researcher Award

Dr. Saloni Sinha | Biochemistry | Best Researcher Award

Dr. Saloni Sinha | Weill Cornell Medicine | United States

Dr. Saloni Sinha is a dedicated biomedical researcher currently serving as a Research Associate at a prominent medical college in New York. With a strong foundation shaped by her doctoral studies in biological sciences from a leading Indian research institution, she has progressed through postdoctoral roles in renowned laboratories, contributing to her growing expertise in liver biology and immune regulation. Her work spans from fundamental mechanisms in hematopoietic stem cell biology to in vivo models of viral infection and liver disease. Over the years, her collaborative spirit and scientific rigor have earned her recognition both in the United States and her native country. She combines a deep curiosity with methodological precision, making her a rising figure in translational biomedical research, particularly at the interface of inflammation, aging, and organ function.

Profiles

ORCID

GOOGLE SCHOLAR

Education

Dr. Saloni’s academic journey began with an honours degree in microbiology from a distinguished college in Kolkata, where her interest in cellular biology took root. She then advanced to earn a master’s degree in biological sciences at a leading Indian research centre, where her work under a notable mentor laid the groundwork for her fascination with stem cell regulation and developmental mechanisms. This path naturally progressed into a doctoral program at the same research centre, where she explored the conserved roles of specialized domain proteins in blood cell homeostasis across model systems. The educational environment she experienced was rigorous and research-intensive, honing both her experimental skills and scientific reasoning. These formative years not only forged her technical foundation, but also instilled a passion for uncovering molecular pathways that govern health and disease, setting the stage for her subsequent research career.

Experience

Dr. Saloni embarked on a postdoctoral journey at a prestigious university in the United States, where she refined her expertise in immunology under the guidance of an established professor. She later transitioned to a prominent medical research institution in New York, embarking on a second postdoctoral appointment where she delved deeply into liver biology, inflammation, and aging processes. Her steadfast contributions in that setting led to her current role as a research associate in medicine, where she continues to advance translational studies using both in vitro and in vivo models. Alongside her research responsibilities, she mentors undergraduate interns, contributes as a teaching assistant in graduate courses, and takes part in editorial and peer review activities for a variety of scientific journals, demonstrating a well-rounded engagement with the academic and research community.

Research Interests

Dr. Saloni’s work centers on the interplay between aging, inflammation, and liver health. She investigates how age-related changes in hepatocyte organization and intercellular communication contribute to organ dysfunction, with an eye toward epithelial and fibrotic pathology. Her projects also explore epigenetic strategies to mitigate liver fibrosis and cancer risk, including the potential repurposing of existing therapeutics to alter disease trajectories in aging tissues. Another facet of her research examines innate immune signaling pathways in hematopoiesis as mechanisms of viral defense, notably in the context of lesser-known but emerging pathogens. Together, her interests unify organ-level physiology, molecular signaling, immune modulation, and translational therapeutic avenues. This integrated approach seeks to yield insights into disease prevention and treatment, particularly in age-susceptible populations.

Awards and Recognition

Dr. Saloni’s scientific promise has been acknowledged through several prestigious recognitions. Among these, she received a pilot research award at her current institution in the United States for her exploration of epigenetic regulation of liver inflammation and fibrosis. Her achievements were also recognized nationally in India with a young scientist medal awarded by a leading academy that celebrates emerging promise, creativity, and excellence in early-career investigators. Earlier in her career, she was invited to present her work at an inspiring research symposium at her doctoral institution. During her doctoral years, she also earned accolades for poster presentations at faculty and in-house symposia. These honors reflect both the novelty and impactful nature of her research contributions, as well as her ability to communicate scientific ideas effectively to diverse academic audiences.

Publication Top Notes

Repurposing GLP-1 Receptor Agonists: A Perspective on Epigenetic Strategies to Combat Fibrosis and Hepatocellular Carcinoma in the Aged Liver

Journal: Cancers (2025-08-08)
Authors: Silvia Hanna, Jason Sethiadi, Qazi Ali, Saloni Sinha

Liver-specific Mettl14 deletion induces nuclear heterotypia and dysregulates RNA export machinery

Journal: Preprint (2024-06-17)
Authors: Keith A Berggren, Saloni Sinha, Aaron E Lin, Michael P Schwoerer, Stephanie Maya, Abhishek Biswas, Thomas R Cafiero, Yongzhen Liu, Hans P Gertje, Saori Suzuki et al.

Mesenteric Parametrial Fat Pad Surgery for in vivo Implantation of Hepatocytes in Nude Mice

Journal: BIO-PROTOCOL (2024-01-04)
Authors: Saloni Sinha, Duc-Huy Nguyen, Nora Hassan, Qazi Ali, Jason Sethiadi, Sergey Tsoy, Robert Schwartz

Organelle stress and alterations in interorganelle crosstalk during liver fibrosis

Journal: Hepatology (Baltimore, Md.) (2023-01-03)
Authors: Sinha S, Hassan N, Schwartz RE

Dual-Reporter System for Real-Time Monitoring of SARS-CoV-2 Main Protease Activity in Live Cells Enables Identification of an Allosteric Inhibition Path

Journal: ACS Bio & Med Chem Au (2022-10-17)
Authors: Bram Y, Duan X, Nilsson-Payant BE, Chandar V, Wu H, Shore D, Fajardo A, Sinha S, Hassan N, Weinstein H et al.

Conclusion

Dr. Saloni Sinha is a dynamic researcher whose career trajectory bridges foundational biological inquiry with translational prospects aimed at enhancing liver health and immune resilience. Her academic training and postdoctoral experiences have equipped her with a sophisticated toolkit, while her research output reflects both depth and relevance in contemporary biomedical challenges. Honored by institutions in two countries, she continues to engage with the scientific community through publications, mentorship, editorial service, and presenting her findings. She stands poised to contribute meaningfully to the development of therapeutic strategies that target aging-related diseases, with her work offering valuable insights into organ homeostasis, inflammation, and regenerative potential.

Dr. Joseph Blondeau | Clinical Microbiology | Best Researcher Award

Dr. Joseph Blondeau | Clinical Microbiology | Best Researcher Award

Royal University Hospital/University of Saskatchewan, Canada.

Dr. Joseph M. Blondeau is a distinguished microbiologist with extensive expertise in clinical microbiology, infectious diseases, and antimicrobial resistance. He currently serves as the Interim Provincial Clinical Lead for Microbiology at the Saskatchewan Health Authority and has been the Head of Clinical Microbiology at the Royal University Hospital in Saskatoon, Canada, since 2000. With a career spanning over three decades, Dr. Blondeau has made significant contributions to medical microbiology, serving as an Adjunct Professor at the University of Saskatchewan while actively consulting for hospitals and laboratories.

Profile

Scopus

🎓 Education

Dr. Joseph M. Blondeau's academic journey began with his B.Sc. in Biology from Dalhousie University in 1983, followed by an Honours B.Sc. in Biology from the same institution in 1985. He continued his studies at Dalhousie, earning a Master of Science in Microbiology in 1985, under the guidance of Dr. J.A. Embil. Dr. Blondeau further advanced his expertise in the field of microbiology, obtaining his Ph.D. in Medical Microbiology from the University of Manitoba in 1989, where he worked under the supervision of Dr. F.Y. Aoki. His solid educational foundation laid the groundwork for his groundbreaking contributions to the field of clinical microbiology and infectious diseases. Dr. Blondeau's early education was completed at Riverview Rural High School in Coxheath, Nova Scotia, where he graduated with his Academic Grade 12 in 1978.

🏢 Professional Experience

Dr. Joseph M. Blondeau has held several prominent positions in the field of microbiology throughout his career. Since 2019, he has served as the Interim Provincial Clinical Lead for Microbiology at the Saskatchewan Health Authority, overseeing the province's microbiology services. In addition to this, Dr. Blondeau has been the Head of Clinical Microbiology at Royal University Hospital and the Saskatoon Health Region since 2000, where he leads clinical microbiology services and research initiatives. He has also been the Head of Clinical Bacteriology/Clinical Microbiologist at Royal University Hospital since 1996, further establishing his expertise in clinical bacteriology. Dr. Blondeau’s academic contributions have been significant, serving as an Adjunct Professor at the University of Saskatchewan since 1991, where he shares his extensive knowledge with students in microbiology and immunology.

Earlier in his career, he served as the Director of Microbiology/Clinical Microbiologist at St. Paul's Hospital in Saskatoon from 1991 to 1996, where he led the microbiology department. Dr. Blondeau has also provided consultancy services in various hospitals and laboratories, including Lloydminster Hospital (1991–1997), Biggar Union Hospital (1991–1992), Prairie Associated Pathologist Laboratory (1991–1992), and MDS – Medical Arts Laboratory (1993–1996), where he advised on microbiological diagnostics and treatment.


🔍 Research Interests

Dr. Blondeau’s research primarily focuses on:

Antimicrobial Resistance 🦠

Clinical Microbiology & Infectious Diseases 🏥

New Antimicrobial Agents & Testing Methods 💊

Diagnostic Microbiology Innovations 🔬

Bacterial Pathogenesis & Emerging Pathogens 🧫

His work contributes to advancing infection control strategies and optimizing antimicrobial treatment options for public health and hospital settings.

🏆 Awards & Honors

Dalhousie Graduate Fellowship – Faculty of Graduate Studies (1983–85)

Dalhousie Teaching Assistantship – Faculty of Graduate Studies (1983–85)

Dalhousie Graduate Travel Grant – First-ever awarded by the Department of Microbiology (1984)

Dalhousie University Honour Award – Certificate of Distinction for outstanding extracurricular activities (1985)

Certified Registered Microbiologist – Canadian College of Microbiologists (1991)

Specialist Microbiologist in Public Health & Medical Microbiology – Canadian College of Microbiologists (1995)

Fellow, The American College of Chest Physicians – (1997)

📚 Selected Publications

Comparison of the Minimum Inhibitory and Mutant Prevention Drug Concentrations for Pradofloxacin and 7 Other Antimicrobial Agents Tested Against Swine Isolates of Actinobacillus pleuropneumoniae and Pasteurella multocida

Authors: Blondeau, J.M., Fitch, S.D.

Published in: Molecules (2024)

Volume: 29(22)

 

Comparative Minimum Inhibitory and Mutant Prevention Drug Concentrations for Pradofloxacin and Seven Other Antimicrobial Agents Tested Against Bovine Isolates of Mannheimia haemolytica and Pasteurella multocida

Authors: Blondeau, J.M., Fitch, S.D.

Published in: Pathogens (2024)

Volume: 13(5)

Citations: 1

Comparative In Vitro Killing by Pradofloxacin in Comparison to Ceftiofur, Enrofloxacin, Florfenicol, Marbofloxacin, Tildipirosin, Tilmicosin, and Tulathromycin Against Bovine Respiratory Bacterial Pathogens

Authors: Blondeau, J.M., Fitch, S.D.

Published in: Microorganisms (2024)

Volume: 12(5)

Citations: 1

Long COVID: A Consequence of Chronic Post-Infectious Inflammation!

Authors: Blondeau, J.M.

Published in: Expert Review of Respiratory Medicine (2024)

Volume: 18(12)